Kestra Advisory Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $314K | Sell |
4,790
-474
| -9% | -$31.1K | ﹤0.01% | 2305 |
|
|
2025
Q1 | $371K | Buy |
5,264
+139
| +3% | +$9.81K | ﹤0.01% | 2016 |
|
|
2024
Q4 | $337K | Sell |
5,125
-207
| -4% | -$13.6K | ﹤0.01% | 2138 |
|
|
2024
Q3 | $377K | Sell |
5,332
-95
| -2% | -$6.71K | ﹤0.01% | 1941 |
|
|
2024
Q2 | $360K | Buy |
5,427
+591
| +12% | +$39.2K | ﹤0.01% | 2000 |
|
|
2024
Q1 | $328K | Buy |
4,836
+78
| +2% | +$5.3K | ﹤0.01% | 1937 |
|
|
2023
Q4 | $294K | Buy |
4,758
+105
| +2% | +$6.49K | ﹤0.01% | 1859 |
|
|
2023
Q3 | $274K | Sell |
4,653
-186
| -4% | -$11K | ﹤0.01% | 1723 |
|
|
2023
Q2 | $289K | Buy |
4,839
+543
| +13% | +$32.4K | ﹤0.01% | 1643 |
|
|
2023
Q1 | $251K | Sell |
4,296
-411
| -9% | -$24K | ﹤0.01% | 1682 |
|
|
2022
Q4 | $292K | Buy |
4,707
+117
| +3% | +$7.26K | ﹤0.01% | 1762 |
|
|
2022
Q3 | $259K | Sell |
4,590
-351
| -7% | -$19.8K | ﹤0.01% | 1692 |
|
|
2022
Q2 | $316K | Buy |
4,941
+258
| +6% | +$16.5K | ﹤0.01% | 1587 |
|
|
2022
Q1 | $303K | Buy |
4,683
+33
| +0.7% | +$2.14K | ﹤0.01% | 1586 |
|
|
2021
Q4 | $309K | Sell |
4,650
-741
| -14% | -$49.2K | ﹤0.01% | 1583 |
|
|
2021
Q3 | $329K | Buy |
5,391
+1,386
| +35% | +$84.6K | ﹤0.01% | 1610 |
|
|
2021
Q2 | $248K | Buy |
4,005
+12
| +0.3% | +$743 | ﹤0.01% | 1705 |
|
|
2021
Q1 | $237K | Sell |
3,993
-1,254
| -24% | -$74.4K | ﹤0.01% | 1614 |
|
|
2020
Q4 | $312K | Buy |
+5,247
| New | +$312K | ﹤0.01% | 1452 |
|